ArticleClinical journal of the American Society of Nephrology : CJASN2022
Kidney Failure Risk Equation and Cost of Care in Patients with Chronic Kidney Disease.
Article in Clinical journal of the American Society of Nephrology : CJASN, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 15 citations in OpenAlex.
- Risk of Progression and Costs of Care for Patients With Chronic Kidney Disease.Kidney medicine · 2026Article
- Profile, follow-up adherence and progression of people with advanced chronic kidney disease in specialized care centers: a retrospective study, Santa Catarina state, Brazil, 2021-2024.Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil · 2026Article
- Enhancing Clinical Decision Support in Nephrology: Addressing Algorithmic Bias Through Artificial Intelligence Governance.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2024Review
- Advanced chronic kidney disease increases complications in anterior cervical discectomies with fusions: An analysis of 75,508 patients.North American Spine Society journal · 2024Article
- Associations of urinary fetuin-A with histopathology and kidney events in biopsy-proven kidney disease.Clinical kidney journal · 2024Article
- Validation of the Klinrisk chronic kidney disease progression model in the FIDELITY population.Clinical kidney journal · 2024Article
- An Approach for Personalized Dynamic Assessment of Chronic Kidney Disease Progression Using Joint Model.Biomedicines · 2024Article
- Risk Prediction and Management of Chronic Kidney Disease in People Living with Type 2 Diabetes Mellitus.Diabetes & metabolism journal · 2024Review
- Costs Associated With Progression of Mildly Reduced Kidney Function Among Medicare Advantage Enrollees.Kidney medicine · 2023Article
- Association of the Kidney Failure Risk Equation With High Health Care Costs.Kidney international reports · 2023Article
- Kidney Function Trajectories and Health Care Costs: Identifying High-Need, High-Cost Patients.Kidney medicine · 2023Article
- Machine Learning Models for the Prediction of Renal Failure in Chronic Kidney Disease: A Retrospective Cohort Study.Diagnostics (Basel, Switzerland) · 2022Article
- Patient Perspectives on Integrating Risk Prediction Into Kidney Care: Opinion Piece.Canadian journal of kidney health and disease · 2022Article
- Value-Based Care in Chronic Kidney Disease: Missing Albuminuria is a Missed Opportunity.Clinical journal of the American Society of Nephrology : CJASN · 2022Article
Corrections and comments
- Commented on by
Authors and funding
9 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesPatients with CKD exhibit heterogeneity in their rates of progression to kidney failure. The kidney failure risk equation (KFRE) has been shown to accurately estimate progression to kidney failure in adults with CKD. Our objective was to determine health care utilization patterns of patients on the basis of their risk of progression. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted a retrospective cohort study of adults with CKD and eGFR of 15-59 ml/min per 1.73 m
resultsIn total, 1003 adults were included in the study. Within the eGFR of 15-29 ml/min per 1.73 m
conclusionsIn patients with CKD and eGFR of 15-59 ml/min per 1.73 m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.